These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
730 related articles for article (PubMed ID: 34384030)
1. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030 [TBL] [Abstract][Full Text] [Related]
2. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis. Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772 [TBL] [Abstract][Full Text] [Related]
4. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation. Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
6. Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis. Liu S; Liu X; Wu J; Zhou W; Ni M; Meng Z; Jia S; Zhang J; Guo S; Lu S; Li Y Medicine (Baltimore); 2020 Dec; 99(49):e23153. PubMed ID: 33285689 [TBL] [Abstract][Full Text] [Related]
7. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis. Fang E; Zhang X Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411 [TBL] [Abstract][Full Text] [Related]
8. Detection of critical genes associated with poor prognosis in breast cancer via integrated bioinformatics analyses. Liu D; Zhang J; Li L; Wang Q; Lan Y J BUON; 2020; 25(6):2537-2545. PubMed ID: 33455094 [TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
10. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay. Zhang L; Sun L; Zhang B; Chen L Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312 [TBL] [Abstract][Full Text] [Related]
11. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma]. Yu Y; Cheng J; Mei CZ; Dai YZ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255 [TBL] [Abstract][Full Text] [Related]
12. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837 [TBL] [Abstract][Full Text] [Related]
13. Integrated transcriptome and network analysis identifies EZH2/CCNB1/PPARG as prognostic factors in breast cancer. Li Y; Chen G; Zhang K; Cao J; Zhao H; Cong Y; Qiao G Front Genet; 2022; 13():1117081. PubMed ID: 36712863 [TBL] [Abstract][Full Text] [Related]
14. Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico. Cai Y; Mei J; Xiao Z; Xu B; Jiang X; Zhang Y; Zhu Y Hereditas; 2019; 156():20. PubMed ID: 31285741 [TBL] [Abstract][Full Text] [Related]
15. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis. Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
17. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation. Zheng Q; Ye H; Zhong H; Wang M Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. Wu JR; Zhao Y; Zhou XP; Qin X Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575 [TBL] [Abstract][Full Text] [Related]
19. Key Genes and Prognostic Analysis in HER2+ Breast Cancer. Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770 [TBL] [Abstract][Full Text] [Related]
20. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis. Zhang X; Yang L; Chen W; Kong M Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]